Analysts estimate that emerging markets are expected to drive 90 percent of the world's pharmaceutical market growth, and differentiated products will be important to this growth. Dilip Shanghvi More Quotes by Dilip Shanghvi More Quotes From Dilip Shanghvi Following the mutual decision to withdraw these plans, the payment bank license will not be pursued. Dilip Shanghvi healthcare Whether the remediation commitments we made are adequate, whether we need to do more ... these are issues we need to assess and understand and probably consult with additional subject matter experts. Dilip Shanghvi company-news Getting the site back in compliance is a major priority and focus. Dilip Shanghvi company-news The Ranbaxy merger has taken more time than originally envisaged. Dilip Shanghvi healthcare I have never seen myself as a promoter. I always evaluate myself as a manager. Dilip Shanghvi manager never myself always If a company is not doing well, it doesn't necessarily mean that it is not a good company. Dilip Shanghvi doing good good-company company Whenever you look at any potential merger or acquisition, you look at the potential to create value for your shareholders. Dilip Shanghvi value your look you Generally, we have competed with ourselves... because I feel that if I compete against somebody, it causes stress. I don't want the process of growth to be stressful. Dilip Shanghvi feel growth stress want I like to win without fighting. But if I can't, then I'm prepared to fight. Dilip Shanghvi fight win like fighting Personally, I feel that a company which looks at problems of other companies and learns from their mistakes is a successful one. Dilip Shanghvi mistakes problems feel looks I have targets for business achievements; I do not have targets for acquisitions. Because if you have targets for acquisitions, you end up making compromises in terms of valuations, and you buy things because you have a target, and it is not good for business. Dilip Shanghvi end good you business Clearly in my mind, I have two distinct positions - owner and manager. So I am open to reviewing my performance as a manager as any other person in Sun Pharma. Dilip Shanghvi i-am performance mind sun The Ranbaxy acquisition doesn't preclude us from making more large acquisitions. The important issue is whether we have the management bandwidth to handle the acquisition. Dilip Shanghvi us more important management The reason we don't give a date by which we will acquire something is because we don't want to create pressure on ourselves to buy something. Dilip Shanghvi will pressure reason want After watching Taro reach the brink of bankruptcy, seeing their shares delisted from trading, hearing endless false promises about receiving audited financial statements, and witnessing an unchecked drain of company resources, the shareholders have clearly had enough. Dilip Shanghvi promises reach company enough A board of directors that cannot produce reliable audited financial statements for almost seven years simply should not remain in office. Dilip Shanghvi cannot financial office years There is no sense in getting excited by market cap because it is a tool. Dilip Shanghvi no-sense cap sense excited Taro will continue to exist as an independent company. Dilip Shanghvi continue will company independent Innovation requires a novel approach to scientific problem solving, higher level of resource commitments over much longer time durations. Dilip Shanghvi over innovation problem time Projects can take years to exhibit proof-of-concept and a few more years to be converted into commercial realities. Dilip Shanghvi commercial more take years
